Forbes March 4, 2024
Bruce Japsen

Walgreens Boots Alliance chief executive officer Tim Wentworth said the company won’t sell its fast-growing Shields specialty pharmacy

A three-byline Bloomberg News story in January said the embattled drugstore chain was “exploring options including a sale of Shields Health Solutions, the specialty pharmacy business it acquired a majority of three years ago.” The business could be valued at more than $4 billion, Bloomberg reported,

But Wentworth, who has been on the job as Walgreens CEO for four months now, swatted down that theory, saying Shields is a key part of the company’s growth strategy. Shields works with hospitals and health systems to set up and run their own on-site specialty pharmacies.

“We love working with health systems and Shields is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients
Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology
AI Identifies New Potential Treatments For Parkinson’s Disease

Share This Article